Status:
UNKNOWN
Multi-site Cohort Study for the Development of Personalized Pharmacotherapy in Patients With Tuberculosis (TB)
Lead Sponsor:
Inje University
Collaborating Sponsors:
Ministry of Science and ICT, Republic of Korea
Conditions:
Tuberculosis
Latent Tuberculosis
Eligibility:
All Genders
Brief Summary
Based on the collected antibiotic concentration data and individual patient's clinical information, a pharmacokinetic analysis report that can be applied for dose adjustment of the individual patient ...
Eligibility Criteria
Inclusion
- Patients diagnosed with Tuberculosis.
- Latent tuberculosis, or Nontuberculous mycobacteria (NTM) disease and currently under treatment with antibiotic drugs.
- Patients who understand and voluntarily sign an informed consent form before any study-related procedures are conducted.
Exclusion
- \- Children (minors) for whom the consent of a legal representative is impossible.
Key Trial Info
Start Date :
July 24 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2025
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT05280886
Start Date
July 24 2018
End Date
February 28 2025
Last Update
April 19 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
General Hospital Dr. Soetomo
Surabaya, East Java, Indonesia, 60286
2
Ibnu Sina Hospital
Gresik, Perum Grand, Indonesia, 61111
3
Inje University Busan Paik Hoapital Clinical Trial Center
Busan, South Korea, 614-735